Serum levels of ALT remained slightly increased, whereas serum levels of AST and hepatic levels TNF-α and IL-6 were not significantly different when T2DM + BE (250 mg/kg)-treated rats were compared to control rats (Figure 3A–D). Here, IL6 is linked to type 2 diabetes mellitus.